logo

For the Inventor, By the Inventor

Solna, Sweden

Xspray Microparticles Ab


USPTO Granted Patents = 16

% Expired Patents = 12.5


Forward Citations = 465

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Mustafa Demirbüker (14 out of 22 patents)

silverMedal Magnus Brisander (12 out of 23 patents)

bronzeMedal Gérald Jesson (12 out of 20 patents)

4.  Martin Malmsten (12 out of 20 patents)

5.  Helene Dérand (12 out of 20 patents)

6.  Thomas Meijer (1 out of 12 patents)

7.  Victor Söderberg (1 out of 10 patents)

8.  Mustafa Demirüker (1 out of 2 patents)

9.  Per X Andersson (1 out of 40 patents)

10.  Martin Malmsten (0 patent)


16 patents:

1. 10799459 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2020-10-13),
2. 10772877 - Pharmaceutical compositions (2020-09-15),
3. 10561645 - Pharmaceutical compositions (2020-02-18),
4. 10561644 - Pharmaceutical compositions (2020-02-18),
5. 10561643 - Pharmaceutical compositions (2020-02-18),
6. 10555937 - Pharmaceutical compositions (2020-02-11),
7. 10314830 - Pharmaceutical compositions (2019-06-11),
8. 10314829 - Pharmaceutical compositions (2019-06-11),
9. 10143683 - Pharmaceutical compositions (2018-12-04),
10. 9833443 - Pharmaceutical compositions (2017-12-05),
11. 9833442 - Pharmaceutical compositions (2017-12-05),
12. 9827230 - Pharmaceutical compositions (2017-11-28),
13. 9456992 - Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix forming component (2016-10-04),
14. 8585943 - Method and arrangement for the production of particles (2013-11-19),
15. 8585942 - Process and arrangement for producing particles utilizing subcritical fluids (2013-11-19),
Company Overview
Xspray Microparticles AB, based in Solna, Sweden, specializes in the development of innovative drug delivery systems utilizing its proprietary microparticle technology. The company focuses on enhancing the bioavailability and therapeutic efficacy of pharmaceutical compounds, particularly in the field of oncology. By leveraging advanced formulation techniques, Xspray aims to improve patient outcomes through more effective and targeted therapies, positioning itself as a key player in the pharmaceutical and biotechnology sectors.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#15 in Solna

#407 in Sweden

#37,788 in the World

Solna, SE
Solna, Sweden

Xspray Microparticles Ab

Forward Citations = 465

9 inventors:

goldMedal Mustafa Demirbüker (14 out of 22 patents)

silverMedal Magnus Brisander (12 out of 23 patents)

bronzeMedal Gérald Jesson (12 out of 20 patents)

4.  Martin Malmsten (12 out of 20 patents)

5.  Helene Dérand (12 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xspray Microparticles Ab. Retrieved from https://idiyas.com/company/xspray-microparticles-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…